The Health Benefits of Microdosing Magic Mushrooms | Canada News Media
Connect with us

Health

The Health Benefits of Microdosing Magic Mushrooms

Published

 on

You’ve probably heard of magic mushrooms, a naturally occurring, popular psychedelic that has been around for thousands of years.

It contains the compound psilocybin, which produces hallucinations in people that consume it. Magic mushrooms have long been used recreationally and religiously, as its advocates often report experiencing spiritual awakenings and meditative states while on a full-on trip.

These intense trips often require more product intake, usually a few grams, to gain the desired hallucinogenic effect. However, more and more Canadians are microdosing magic mushrooms, using a minuscule amount to achieve different but still positive results.

What Is Microdosing?

Microdosing is a relatively new phenomenon. It has gained initial traction across psychonauts or psychedelic enthusiasts and is also attracting researchers, scientists, and business people.

There is no precise amount yet to what constitutes a microdose with research on the subject still in its infancy. The consensus is that a tiny amount of a psychedelic drug isn’t enough to cause a full trip or hallucination.

Despite having a milder effect than a regular trip, its proponents attest that the practice offers significant benefits to one’s mind and general well-being.

The Health Benefits of Microdosing Shrooms

Despite having been in existence for millennia, research on psychedelics, particularly psilocybin, is still in its infancy due to the prohibition of these substances in countries worldwide.

However, current research has shown promising results. A study in Harm Reduction Journal has elaborated on the many benefits of microdosing psychedelics, including magic mushrooms.

Improved Focus and Concentration

In the study mentioned above, 14.8 percent of participants reported experiencing improved focus and concentration.

 

Another study also reported an increased psychological functioning on days when the participants microdosed. However, there is not much evidence supporting these effects carried over in days when the participants did not microdose.

Creativity

Creativity is one of the main reasons people use psychedelics. Magic mushrooms could produce vivid hallucinations that inspire creativity or spiritual experiences in regular or larger doses.

Many people report experiencing increased creativity even when microdosing. However, many of these experiences remain anecdotal and need to be backed up by further research.

Improved Mental Health

Many people who microdose report doing so due to its capability to help reduce stress and anxiety in their daily lives.

In a 2018 international survey, 21 percent of respondents reported microdosing to self-medicate for depression, seven percent for anxiety, nine percent for other mental health problems, and two percent to aid in stopping or reducing substance use.

Social Benefits

When putting together all the reported benefits of microdosing psilocybin mushrooms, many people observe being more able to cope with their daily lives, especially when handling or facing other people.

This effect could be due to reduced stress and an improved mood. Handling negative feelings more effectively allows people to become more friendly, open, and less irritable in stressful or high-pressure situations.

Despite being a relatively new concept, microdosing magic mushrooms and other psychedelics looks promising, especially in helping treat mental health problems and improving one’s quality of life.

Still, it’s essential to take note of relevant studies as they arise to ensure a more objective view of the practice and minimize any potential harm that may come.

 

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version